{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T08:18:00Z","timestamp":1781770680657,"version":"3.54.5"},"reference-count":30,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1842,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1111\/j.1399-3046.2010.01335.x","type":"journal-article","created":{"date-parts":[[2010,5,4]],"date-time":"2010-05-04T21:03:20Z","timestamp":1273007000000},"page":"770-778","source":"Crossref","is-referenced-by-count":16,"title":["Induction therapy in pediatric kidney transplant recipients discharged with a triple drug immunosuppressive regimen"],"prefix":"10.1111","volume":"14","author":[{"given":"Marcelo S.","family":"Sampaio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Poommipanit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Tien","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavani N.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong W.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suphamai","family":"Bunnapradist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,8,16]]},"reference":[{"key":"10.1111\/j.1399-3046.2010.01335.x-BIB1|cit1","unstructured":"N orth A merican P ediatric R enal T rials and C ollaborative S tudies (NAPRTCS) 2008 Annual Report: page 3-2 http:\/\/spitfireemmescom\/study\/ped\/annlrept\/Annual%20Report%20-2008pdf"},{"key":"10.1111\/j.1399-3046.2010.01335.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/S0041-1345(02)03131-7","article-title":"Effect of daclizumab, tacrolimus, and mycophenolate mofetil in pediatric first renal transplant recipients","volume":"34","author":"Ciancio","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1399-3046.2010.01335.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/ndt\/17.7.1304","article-title":"Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation","volume":"17","author":"Clark","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1399-3046.2010.01335.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1016\/S0041-1345(02)03486-3","article-title":"IL-2 antibody induction and the outcome of pediatric renal transplants","volume":"34","author":"Garcia","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1399-3046.2010.01335.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S0041-1345(03)00578-5","article-title":"Immunoprophylaxis with Simulect (basiliximab) in pediatric kidney transplant recipients: Results from routine clinical practice at 5 kidney transplant units","volume":"35","author":"Garcia Meseguer","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1399-3046.2010.01335.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s004670100642","article-title":"Basiliximab induction improves the outcome of renal transplants in children and adolescents","volume":"16","author":"Swiatecka-Urban","year":"2001","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/j.1399-3046.2010.01335.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1111\/j.1600-6143.2006.01367.x","article-title":"A prospective, randomized, multicenter trial of tacrolimus-based therapy with or without basiliximab in pediatric renal transplantation","volume":"6","author":"Grenda","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1399-3046.2010.01335.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1097\/TP.0b013e318188af15","article-title":"Efficacy and safety of basiliximab in pediatric renal transplant patients receiving cyclosporine, mycophenolate mofetil, and steroids","volume":"86","author":"Offner","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/j.1399-3046.2010.01335.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00467-008-0931-x","article-title":"Multicentre prospective randomised trial of tacrolimus, azathioprine and prednisolone with or without basiliximab: Two-year follow-up data","volume":"24","author":"Webb","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/j.1399-3046.2010.01335.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00467-002-0942-y","article-title":"Short-term outcomes of thymoglobulin induction in pediatric renal transplant recipients","volume":"17","author":"Ault","year":"2002","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/j.1399-3046.2010.01335.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1399-3046.2006.00509.x","article-title":"Five years\u2019 experience with thymoglobulin induction in a pediatric renal transplant population","volume":"10","author":"Colleen Hastings","year":"2006","journal-title":"Pediatr Transplant"},{"key":"10.1111\/j.1399-3046.2010.01335.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1399-3046.2007.00764.x","article-title":"Comparison of outcomes with low-dose anti-thymocyte globulin, basiliximab or no induction therapy in pediatric kidney transplant recipients: A retrospective study","volume":"12","author":"Baron","year":"2008","journal-title":"Pediatr Transplant"},{"key":"10.1111\/j.1399-3046.2010.01335.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1097\/01.TP.0000158325.12837.A2","article-title":"Thymoglobulin versus ATGAM induction therapy in pediatric kidney transplant recipients: A single-center report","volume":"79","author":"Khositseth","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1399-3046.2010.01335.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/01.tp.0000281907.54832.cb","article-title":"Decreased incidence of acute rejection in adolescent kidney transplant recipients using antithymocyte induction and triple immunosuppression","volume":"84","author":"Schwartz","year":"2007","journal-title":"Transplantation"},{"key":"10.1111\/j.1399-3046.2010.01335.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00467-001-0795-9","article-title":"Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation","volume":"17","author":"Trompeter","year":"2002","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/j.1399-3046.2010.01335.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1399-3046.2005.00334.x","article-title":"Four-year data after pediatric renal transplantation: A randomized trial of tacrolimus vs. cyclosporin microemulsion","volume":"9","author":"Filler","year":"2005","journal-title":"Pediatr Transplant"},{"key":"10.1111\/j.1399-3046.2010.01335.x-BIB17|cit17","first-page":"91","article-title":"Mycophenolate mofetil in pediatric renal transplantation","volume":"55","author":"Weber","year":"2003","journal-title":"Minerva Urol Nefrol"},{"key":"10.1111\/j.1399-3046.2010.01335.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/00007890-200103150-00010","article-title":"Mycophenolate mofetil in pediatric renal transplantation without induction therapy: Results after 12\u2003months of treatment. German Pediatric Renal Transplantation Study Group","volume":"71","author":"Staskewitz","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1399-3046.2010.01335.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1399-3046.2005.00267.x","article-title":"Mycophenolate mofetil in pediatric renal transplantation: Non-induction vs. induction with basiliximab","volume":"9","author":"Ojogho","year":"2005","journal-title":"Pediatr Transplant"},{"key":"10.1111\/j.1399-3046.2010.01335.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/01.TP.0000109643.32659.C4","article-title":"Interleukin 2 receptor antagonists for renal transplant recipients: A meta-analysis of randomized trials","volume":"77","author":"Webster","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1399-3046.2010.01335.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1600-6143.2005.01213.x","article-title":"Decreased risk of renal allograft thrombosis associated with interleukin-2 receptor antagonists: A report of the NAPRTCS","volume":"6","author":"Smith","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1399-3046.2010.01335.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa060068","article-title":"Rabbit antithymocyte globulin versus basiliximab in renal transplantation","volume":"355","author":"Brennan","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1399-3046.2010.01335.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0140-6736(97)09278-7","article-title":"Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group","volume":"350","author":"Nashan","year":"1997","journal-title":"Lancet"},{"key":"10.1111\/j.1399-3046.2010.01335.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00007890-199901150-00019","article-title":"Reduction of acute renal allograft rejection by daclizumab. Daclizumab Double Therapy Study Group","volume":"67","author":"Nashan","year":"1999","journal-title":"Transplantation"},{"key":"10.1111\/j.1399-3046.2010.01335.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/00007890-200109150-00017","article-title":"Results of 3-year phase III clinical trials with daclizumab prophylaxis for prevention of acute rejection after renal transplantation","volume":"72","author":"Bumgardner","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1399-3046.2010.01335.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00007890-199901270-00016","article-title":"Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group","volume":"67","author":"Kahan","year":"1999","journal-title":"Transplantation"},{"key":"10.1111\/j.1399-3046.2010.01335.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM199801153380304","article-title":"Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group","volume":"338","author":"Vincenti","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1399-3046.2010.01335.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1111\/j.1600-6143.2007.01860.x","article-title":"Efficacy of anti-IL-2 receptor antibodies compared to no induction and to antilymphocyte antibodies in renal transplantation","volume":"7","author":"Patlolla","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1399-3046.2010.01335.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1600-6143.2006.01675.x","article-title":"Younger age and antibody induction increase the risk for infection in pediatric renal transplantation: A NAPRTCS report","volume":"7","author":"Puliyanda","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1399-3046.2010.01335.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1399-3046.2007.00704.x","article-title":"Contributions of the transplant registry: The 2006 Annual Report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS)","volume":"11","author":"Smith","year":"2007","journal-title":"Pediatr Transplant"}],"container-title":["Pediatric Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-3046.2010.01335.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1399-3046.2010.01335.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T01:05:28Z","timestamp":1625619928000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-3046.2010.01335.x"}},"subtitle":["Induction in pediatric renal transplant"],"short-title":[],"issued":{"date-parts":[[2010,8,16]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,9]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1399-3046.2010.01335.x","relation":{},"ISSN":["1397-3142"],"issn-type":[{"value":"1397-3142","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8,16]]}}}